Looking Under the Hood: PBM Contracts

Lawton Robert Burns ()
Additional contact information
Lawton Robert Burns: The Wharton School, University of Pennsylvania

Chapter Chapter 13 in The Healthcare Value Chain, 2022, pp 581-613 from Springer

Abstract: Abstract The prior chapter discussed the intertwined issues of rebates, administrative fees, and transparency in the relationships between pharmaceutical manufacturers and PBMs. The chapter also discussed the related issue of how these rebates and fees are passed along to health plan clients and how PBMs are compensated for their efforts. These upstream and downstream contracts (and funds flows) lie at the center of the controversy surrounding PBMs.

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-10739-9_13

Ordering information: This item can be ordered from
http://www.springer.com/9783031107399

DOI: 10.1007/978-3-031-10739-9_13

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().